Could a probiotic boost breast cancer treatment? new trial aims to find out
Disease control
Not yet recruiting
This Phase II trial will test whether adding a live biotherapeutic product called MO-03 (a type of probiotic) to standard chemotherapy and the immunotherapy drug pembrolizumab can improve outcomes for 50 people with early-stage triple-negative breast cancer. Participants will tak…
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC